WASHINGTON — The Food and Drug Administration on Friday authorized Pfizer-BioNTech’s coronavirus vaccine for emergency use in children 5 to 11, a move eagerly anticipated by millions of families looking to protect some of the only remaining Americans left out of the vaccination campaign. About 28 million children in the group will be eligible to receive one-third of the adult dose, with two injections three weeks apart. If the Centers for Disease Control and Prevention signs off, as is expected, they could start getting shots as early as Wednesday. States started ordering doses last week, under a formula based on how many children they have in the age group. “To be able to know that your child is protected and not going to get severely ill by going to school is an incredible psychological relief.”

Source: New York Times October 29, 2021 23:05 UTC